Company intelligence / Profile preview

Wonder

China

Ownership: Private
Development stage: Other

Overview

Wonder Biotech is a commercial-stage biotech focused on high-quality plant and fungal extracts adhering to ISO9001 and GMP standards for global pharmaceutical, nutraceutical, food, and cosmetic industries. They have their own 85-acre GAP cultivation base, state-of-the-art equipment, extensive quality control, and capabilities in development and commercial-scale manufacturing[1][4].

Therapeutic areas: DermatologyOther
Modalities: Botanical extractFungal extractSmall molecule
Industry: Chemicals & Materials

Partnerships

Collaborates with large planting bases and possibly downstream pharma/nutra/food companies, but no specific major pharma biotech partners named[1].

Beyond the preview

Go deeper on Wonder.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wonder.

Explore the full profile